Ryan Specialty Q2 Earnings Beat, Raises Guidance Margin Outlook
RYAN sits 69% above its 52-week low of $29.28.
Summary
Ryan Specialty posted Q2 revenue of $916.6M and adjusted EPS of $0.74, both above expectations. The company maintained its organic growth outlook and updated margin guidance, while returning $284.5M to shareholders.
Key Events · Earnings and Guidance · RYAN
-
Q2 Revenue and EPS Beat
Total revenue grew 7.2% YoY to $916.6M, beating consensus by 5%. Adjusted diluted EPS rose 12.1% to $0.74, exceeding estimates by 12%.
-
Organic Growth Remains Strong
Organic revenue growth rate was 6.7% for the quarter, driven by new client wins and strong retention, though slightly below the prior-year period's 7.1%.
-
Full-Year Guidance Updated
Company maintained mid-single-digit organic revenue growth outlook but now expects Adjusted EBITDAC margin to decline 50-100 bps year-over-year, reflecting restructuring costs.
-
Capital Return to Shareholders
Returned $284.5M in Q2, including $260M in share repurchases (8.1M shares) and $24.5M in dividends. Declared a $0.13 quarterly dividend payable August 25.
Analysis · RYAN · Finance
A strong second quarter saw revenue of $916.6M beat consensus by 5%, while adjusted EPS of $0.74 crushed estimates by 12%. Organic growth held firm at 6.7%, and the company returned $284.5M to shareholders through buybacks and dividends. Although GAAP net income dipped on higher operating costs, the adjusted figures underscore underlying momentum. The updated guidance for Adjusted EBITDAC margin—now expected to decline 50-100 bps—reflects ongoing investment in the Empower restructuring program, but the maintained mid-single-digit organic growth target signals confidence in the core business.
At the time of this filing, RYAN was trading at $49.50 on NYSE in the Finance sector, with a market capitalization of approximately $11.6B. The 52-week trading range was $29.28 to $61.85. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.